Market Research Logo

North America Newborn Screening Market Forecast 2019-2027

North America Newborn Screening Market Forecast 2019-2027

KEY INSIGHTS

The North American newborn screening market is driven by the healthcare expenditure coupled with demand for quality healthcare affirms the adoption of new and different healthcare diseases which is positively supplementing growth in this region.

The market in this region is primarily driven by compensatory rules & regulations of newborn screening market in the United States along with the presence of many newborn screening centers & rising hearing disorders in newborn babies in Canada. The new born screening has its primary application in detection and diagnosis of diseases that mainly occur in infants and newborn babies

By the end of the forecast period of 2019-2027, the market is expected to grow at a CAGR of 13.73%.

MARKET INSIGHTS

The North American newborn screening market is segmented on the basis of technology, test types, and products. The growing incidence of fetal health-related abnormalities and government support towards new child healthcare management are factors that are significantly driving market growth.

The market in this region is driven by compensatory rules & regulations of the newborn screening market in United States along with the presence of many newborn screening centers & rising hearing disorders in newborn babies in Canada.

COMPETITIVE INSIGHTS

Leading players in this market include Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Supportive Government Policies In Us And Canada
3.2.2. Demand For Newborn Screening Instruments Is Rising Steadily
3.2.3. Growth In Dry Blood Spot Test
3.2.4. Techniques Used In Newborn Screening Tests
4. Market Dynamics
4.1. Etymology Of Newborn Screening
4.2. Market Scope & Definition
4.3. Market Drivers
4.3.1. Increase In Occurrences Of Newborn Diseases
4.3.2. Growing Number Of Infants With Birth Defect
4.3.3. Backing Of Government Towards Newborn Child Health
4.3.4. Rising Awareness For Pediatric Congenital Heart Disease
4.4. Market Restraints
4.4.1. Absence Of Proper Healthcare Infrastructure For Newborn Babies In Developing Countries
4.4.2. Socio-economic Hurdles In The Implementation Of Newborn Child Screening
4.5. Market Opportunities
4.5.1. Increasing Fertility Rates Across The Globe Is Creating Dynamic Growth
4.5.2. Newborn Screening Helps In Early Identification And Management Of Affected Newborns
4.5.3. Technological Advancements In Newborn Screening
4.5.4. Increase In Number Of Pregnant Women With Advanced Maternal Age
4.6. Market Challenges
4.6.1. Dearth Of Skilled Professional In Healthcare Industry
4.6.2. Maintenance Of Equipment In Hospital
5. Market By Product
5.1. Newborn Screening Instruments
5.2. Newborn Screening Reagents & Assay Kits
6. Market By Test Type
6.1. Hearing Screen Test
6.2. Critical Congenital Heart Disease (Cchd) Test
6.3. Dry Blood Spot Test
7. Market By Technology
7.1. Tandem Mass Spectrometry
7.2. Pulse Oximetry
7.3. Enzyme Based Assays
7.4. Dna Based Assays
7.5. Electrophoresis
7.6. Others
8. Key Analytics
8.1. Porter’s Five Force Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Suppliers
8.1.4. Bargaining Power Of Buyers
8.1.5. Threat Of Competitive Rivalry
8.2. Key Buying Criteria
8.2.1. Reliability
8.2.2. Cost
8.2.3. Availability
8.2.4. Technological Advancement
8.3. Opportunity Matrix
8.4. Vendor Landscape
8.5. Value Chain Analysis
8.5.1. Raw Material Suppliers
8.5.2. Manufacturers
8.5.3. Distributors
8.5.4. End-users
8.6. Legal, Policy & Regulatory Framework
9. North America
9.1. United States
9.2. Canada
10. Competitive Landscape
10.1. Market Share Analysis
10.2. Corporate Strategies
10.2.1. Product Launch
10.3. Company Profiles
10.3.1. Sciex
10.3.1.1. Overview
10.3.1.2. Product Portfolio
10.3.1.3. Strategic Initiatives
10.3.1.4. Scot Analysis
10.3.2. Biotek Instruments Inc.
10.3.2.1. Overview
10.3.2.2. Product Portfolio
10.3.2.3. Strategic Initiatives
10.3.2.4. Scot Analysis
10.3.3. Bio-rad Laboratories Inc.
10.3.3.1. Overview
10.3.3.2. Product Portfolio
10.3.3.3. Strategic Initiatives
10.3.3.4. Scot Analysis
10.3.4. Cardinal Health Inc.
10.3.4.1. Overview
10.3.4.2. Product Portfolio
10.3.4.3. Strategic Initiatives
10.3.4.4. Scot Analysis
10.3.5. Ge Healthcare Limited
10.3.5.1. Overview
10.3.5.2. Product Portfolio
10.3.5.3. Strategic Initiatives
10.3.5.4. Scot Analysis
10.3.6. Agilent Technologies Inc.
10.3.6.1. Overview
10.3.6.2. Product Portfolio
10.3.6.3. Strategic Initiatives
10.3.6.4. Scot Analysis
10.3.7. Masimo Corporation
10.3.7.1. Overview
10.3.7.2. Product Portfolio
10.3.7.3. Strategic Initiatives
10.3.7.4. Scot Analysis
10.3.8. Natus Medical Incorporated
10.3.8.1. Overview
10.3.8.2. Product Portfolio
10.3.8.3. Strategic Initiatives
10.3.8.4. Scot Analysis
10.3.9. Medtronic Plc
10.3.9.1. Overview
10.3.9.2. Product Portfolio
10.3.9.3. Strategic Initiatives
10.3.9.4. Scot Analysis
10.3.10. Thermo Fisher Scientific Inc.
10.3.10.1. Overview
10.3.10.2. Product Portfolio
10.3.10.3. Strategic Initiatives
10.3.10.4. Scot Analysis
10.3.11. Neogen Labs Pvt. Ltd.
10.3.11.1. Overview
10.3.11.2. Product Portfolio
10.3.11.3. Strategic Initiatives
10.3.11.4. Scot Analysis
10.3.12. Perkinelmer Inc.
10.3.12.1. Overview
10.3.12.2. Product Portfolio
10.3.12.3. Strategic Initiatives
10.3.12.4. Scot Analysis
10.3.13. Zentech S.A.
10.3.13.1. Overview
10.3.13.2. Product Portfolio
10.3.13.3. Strategic Initiatives
10.3.13.4. Scot Analysis
10.3.14. Waters Corporation
10.3.14.1. Overview
10.3.14.2. Product Portfolio
10.3.14.3. Strategic Initiatives
10.3.14.4. Scot Analysis
10.3.15. Trivitron Healthcare
10.3.15.1. Overview
10.3.15.2. Product Portfolio
10.3.15.3. Strategic Initiatives
10.3.15.4. Scot Analysis
List Of Tables
Table 1. North America Newborn Screening Market, By Country, 2019-2027 (In $ Million)
Table 2. North America Incidence Of Chromosomal Abnormalities In Newborns
Table 3. Leading Cause Of Infant Death In The United States
Table 4. Infant Mortality Rate In Developing Countries (Total Death/ 1000 Live Births)
Table 5. North America Newborn Screening Market, By Product, 2019-2027, (In $ Million)
Table 6. North America Newborn Screening Market, By Test Type, 2019-2027, (In $ Million)
Table 7. North America Newborn Screening Market, By Technology, 2019-2027, (In $ Million)
Table 8. Opportunity Matrix
Table 9. Vendor Landscape
Table 10. Regulatory Framework
Table 11. North America Newborn Screening Market, By Country, 2019-2027, (In $ Million)
Table 12. List Of Product Launches
List Of Figures
Figure 1. North America Newborn Screening Instruments Market, By Technology, 2018 & 2027 (In %)
Figure 2. Causes Of Death Among Newborns North America (0-27 Days)
Figure 3. Fertility Rate (Average Births Per Woman In %) 2017
Figure 4. North America Newborn Screening Market, By Newborn Screening Instruments, 2019-2027 (In $ Million)
Figure 5. North America Newborn Screening Market, By Newborn Screening Reagents & Assay Kits, 2019-2027 (In $ Million)
Figure 6. North America Newborn Screening Market, By Hearing Screen Test, 2019-2027 (In $ Million)
Figure 7. North America Newborn Screening Market, By Critical Congenital Heart Disease (Cchd) Test, 2019-2027 (In $ Million)
Figure 8. North America Newborn Screening Market, By Dry Blood Spot Test, 2019-2027 (In $ Million)
Figure 9. North America Newborn Screening Market, By Tandem Mass Spectrometry, 2019-2027 (In $ Million)
Figure 10. North America Newborn Screening Market, By Pulse Oximetry, 2019-2027 (In $ Million)
Figure 11. North America Newborn Screening Market, By Enzyme Based Assays, 2019-2027 (In $ Million)
Figure 12. North America Newborn Screening Market, By Dna Based Assays, 2019-2027 (In $ Million)
Figure 13. North America Newborn Screening Market, By Electrophoresis, 2019-2027 (In $ Million)
Figure 14. North America Newborn Screening Market, By Others, 2019-2027 (In $ Million)
Figure 15. Porter’s Five Force Analysis
Figure 16. Key Buying Impact Analysis
Figure 17. Value Chain Analysis
Figure 18. North America Newborn Screening Market, Regional Outlook, 2018 & 2027 (In %)
Figure 19. United States Newborn Screening Market, 2019-2027 (In $ Million)
Figure 20. Canada Newborn Screening Market, 2019-2027 (In $ Million)
Figure 21. Industry Player Positioning In 2018 (In %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook